Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline Resectable Carcinoma”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableStudy completedNCT02218801
What this trial is testing

A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program

Who this might be right for
Liver MetastasisColorectal Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 219
Testing effectiveness (Phase 2)Looking for participantsNCT06538857
What this trial is testing

CEB-01 in Locally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
CEBIOTEX 39
Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Testing effectiveness (Phase 2)WithdrawnNCT06017297
What this trial is testing

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma

Who this might be right for
Borderline Resectable CarcinomaBiliary Tract Cancer
Georgetown University
Early research (Phase 1)Study completedNCT02508246
What this trial is testing

WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Washington 12
Testing effectiveness (Phase 2)Study completedNCT02427841
What this trial is testing

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaResectable Pancreatic Carcinoma
OHSU Knight Cancer Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT06904014
What this trial is testing

Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC

Who this might be right for
HCC
Lei ZHAO 40
Testing effectiveness (Phase 2)Study completedNCT02976909
What this trial is testing

Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Yuhong Li 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05925530
What this trial is testing

Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 142
Testing effectiveness (Phase 2)Active Not RecruitingNCT07339488
What this trial is testing

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Borderline Resectable CarcinomaUnresectable CancerEsophageal Squamous Cell Carcinoma (ESCC)+4 more
Chuangzhen Chen 43
Large-scale testing (Phase 3)Not Yet RecruitingNCT06923475
What this trial is testing

Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma

Who this might be right for
Extrahepatic CholangiocarcinomaPerihilar CholangiocarcinomaDistal Cholangiocarcinoma+2 more
Amsterdam UMC, location VUmc 150
Very early researchStudy completedNCT03153410
What this trial is testing

Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Testing effectiveness (Phase 2)Study completedNCT05471674
What this trial is testing

Neoadjuvant Anti-PD1 in HCC

Who this might be right for
Hepatocellular CarcinomaHCCLiver Cancer
Dr Tan-to CHEUNG 20
Not applicableUnknownNCT05511116
What this trial is testing

Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI

Who this might be right for
Pancreas CancerAdenocarcinoma
Fondation Hôpital Saint-Joseph 48
Testing effectiveness (Phase 2)Looking for participantsNCT05241249
What this trial is testing

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
Susan E. Bates 37
Early research (Phase 1)Ended earlyNCT01525069
What this trial is testing

Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaLiver Neoplasms
Washington University School of Medicine 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07030140
What this trial is testing

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaHilar CholangiocarcinomaBile Duct Cancer
Jinbo Yue 38
Large-scale testing (Phase 3)Looking for participantsNCT06714604
What this trial is testing

Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaBorderline Resectable Pancreatic CarcinomaPancreas Cancer+3 more
Sahlgrenska University Hospital 432
Early research (Phase 1)Looking for participantsNCT06800339
What this trial is testing

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Maryland, Baltimore 18
Testing effectiveness (Phase 2)Looking for participantsNCT06810609
What this trial is testing

Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

Who this might be right for
Lung Cancer Non-Small Cell Cancer (NSCLC)
University Hospital, Bonn 176
Load More Results